- Science
- Global
How Argonaute, a key protein for RNA therapeutics, becomes activated
- June 10, 2026 at 3:00 PM
- 13 views
RNA therapeutics have emerged as one of the most promising new classes of medicines. Eight small interfering RNA (siRNA) drugs have already been approved worldwide for the treatment of genetic diseases, yet scientists have not fully understood one of the most fundamental steps underlying their function: how Argonaute, the core protein responsible for gene silencing, becomes activated.
Originally published at Phys.org